Immuno Oncology Biopharmaceutical Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ACHL | C | Achilles Therapeutics plc | 5.04 | |
CKPT | F | Checkpoint Therapeutics, Inc. | 0.49 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer Immunotherapy
Medicine
Advanced Non Small Cell Lung Cancer
Antibodies
Antineoplastic Drugs
Bladder Cancer
Breakthrough Therapy
Cancer
Cancer Treatment
Checkpoint Inhibitor
Chemotherapy
Clinical Medicine
Epidermal Growth Factor Receptor
Head And Neck Cancer
Head And Neck Squamous Cell Carcinoma
Immune Checkpoint
Immune System
Immunology
Melanoma
Necrosis
Related ETFs - A few ETFs which own one or more of the above listed Immuno Oncology Biopharmaceutical stocks.
Date | Stock | Title |
---|---|---|
Mar 24 | CKPT | Checkpoint Therapeutics Full Year 2023 Earnings: Misses Expectations |
Related Industries:
Biotechnology
Related Stock Lists:
Cancer Immunotherapy
Medicine
Advanced Non Small Cell Lung Cancer
Antibodies
Antineoplastic Drugs
Bladder Cancer
Breakthrough Therapy
Cancer
Cancer Treatment
Checkpoint Inhibitor
Chemotherapy
Clinical Medicine
Epidermal Growth Factor Receptor
Head And Neck Cancer
Head And Neck Squamous Cell Carcinoma
Immune Checkpoint
Immune System
Immunology
Melanoma
Necrosis
- Immuno Oncology Biopharmaceutical
Immuno-oncology biopharmaceuticals are drugs that use the body’s own immune system to fight cancer. These drugs work by stimulating the body’s natural immune response to recognize and attack cancer cells. Immuno-oncology biopharmaceuticals are a relatively new type of cancer treatment and are being studied in clinical trials to determine their effectiveness in treating different types of cancer.
Recent Comments
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
- TraderMike on Trades of the Week: Feb 12 - Feb 16, 2024
- Cos3 on Trades of the Week: Feb 12 - Feb 16, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
From the Blog
Featured Articles